🔗 Permalink

Inventor profile of:

Pascal Grenier

City:

Kappelen

Country:

France

Published Applications:

31

Last publication date:

2016-09-15

Top Assignees for applications by Pascal Grenier

The entities that hold a legal rights for patent applications filed by inventor Grenier Pascal:

Jagotec AG 22 Muttenz, Switzerland
Jagotec AG 1 Chippenham, United Kingdom

Recent patent applications by Grenier Pascal

Pascal Grenier from Kappelen, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2016-09-15

US20160263045A1

Human necessities

Floating gastric retentive dosage form

#2 | 2016-09-08

US20160256396A1

Human necessities

Delayed release tablet with defined core geometry

#3 | 2016-01-14

US20160008288A1

Human necessities

Controlled release compositions

#4 | 2015-05-14

US20150133416A1

Human necessities

Pharmaceutical Composition Comprising Abiraterone Acetate

#5 | 2014-11-06

US20140328912A1

Human necessities

Delayed release tablet with defined core geometry

#6 | 2014-09-11

US20140255499A1

Performing operations; transporting

Method of Forming Fine Particles of a Drug Substance

#7 | 2014-08-28

US20140243296A1

Human necessities

Organic Compounds

#8 | 2013-05-16

US20130122061A1

Human necessities

Delayed release tablet with defined core geometry

#9 | 2013-05-02

US20130108695A1

Human necessities

Floating gastric retentive dosage form

#10 | 2013-03-28

US20130079415A1

Human necessities

Compositions comprising amphetamin and lisdexamfetamine

#11 | 2012-08-23

US20120213910A1

Human necessities

Tablets with Site- and Time- Controlled Gastrointestinal Release of Active Ingredient

#12 | 2012-07-12

US20120177739A1

Human necessities

Delayed release tablet with defined core geometry

#13 | 2012-07-12

US20120177734A1

Human necessities

Delayed release tablet with defined core geometry

#14 | 2011-07-21

US20110177167A1

Human necessities

Hydrophilic/lipophilic polymeric matrix dosage formulation

#15 | 2011-01-20

US20110014352A1

Performing operations; transporting

Method and apparatus for producing a centred compression coated tablet

#16 | 2010-11-23

US10473055

Pharmaceutical tablet system that floats on gastric fluid for multipulse release of active substance, and respective processes of producing same and a cup-shaped envelope of same

#17 | 2010-11-18

US20100291209A1

Human necessities

ORGANIC COMPOUNDS

#18 | 2010-09-16

US20100233259A1

Human necessities

DOSAGE FORM OF ROPINIROLE

#19 | 2010-08-05

US20100196475A1

Human necessities

CONTROLLED RELEASE TABLET FORMULATION CONTAINING MAGNESIUM ALUMINOMETASILICATE

#20 | 2010-01-07

US20100003320A1

Human necessities

Hydrophilic/lipophilic polymeric matrix dosage formulation

#21 | 2009-12-03

US20090297601A1

Human necessities

Dosage form time-lagged of drugs for the therapy of insomnia

#22 | 2008-12-25

US20080317841A1

Human necessities

Pharmaceutical composition containing coated, floating particles

#23 | 2008-09-11

US20080221174A1

Human necessities

CONTROLLED RELEASE NISOLDIPINE COMPOSITIONS

#24 | 2008-03-20

US20080069886A1

Human necessities

Spironolactone nanoparticles, compositions and methods related thereto

#25 | 2008-03-13

US20080063711A1

Human necessities

Controlled release nisoldipine compositions

#26 | 2008-03-06

US20080057123A1

Human necessities

Controlled Release Formulations

#27 | 2007-11-15

US20070264336A1

Human necessities

Hydrophilic/lipophilic polymeric matrix dosage formulation

#28 | 2007-06-28

US20070148229A1

Human necessities

Tablet with coloured core

#29 | 2007-05-17

US20070110807A1

Human necessities

Delayed release tablet with defined core geometry

#30 | 2006-03-30

US20060067892A1

Human necessities

Topical nanoparticulate spironolactone formulation

#31 | 2005-05-05

US20050095297A1

Human necessities

Nanoparticulate formulations of fenofibrate

InventorID:

167667 ⎘